Acadian Asset Management LLC Bluebird Bio, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $20,996 - $39,228	-1,868 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.04 - $22.09 $33,698 - $41,264	1,868 New	1,868 $60,000
Q1 2021 May 11, 2021	SELL	$16.59 - $33.89 $9,688 - $19,791	-584 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$27.5 - $37.92 $26,455 - $36,479	-962 Reduced 62.23%	584 $25,000
Q3 2020 Nov 09, 2020	BUY	$34.44 - $43.75 $53,244 - $67,637	1,546 New	1,546 $84,000

149

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $652M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.